期刊文献+

腹腔化疗对老年进展期胃癌患者术后细胞免疫的影响 被引量:2

Effect of intraperitoneal chemotherapy on immune function in elderly patients with gastric cancer after radical operation
下载PDF
导出
摘要 目的探讨老年胃癌患者手术后腹腔化疗对免疫功能的影响。方法对我院1997年1月至2002年12月60岁及以上接受胃癌根治性手术并进行腹腔化疗的49例患者前后细胞免疫检测,并与我院同期接受胃癌根治性手术并单独行静脉化疗的37例患者进行比较,以健康老年人作为正常对照组。所有患者于化疗前1d和化疗后7d早晨空腹时静脉采血,正常对照组于体检当日早晨空腹时静脉采血,测定血清中NK细胞和T细胞亚群。结果老年胃癌患者手术后CD4+和NK细胞水平明显低于正常对照组;老年胃癌患者化疗后CD4+、CD4+/CD8+和NK细胞水平低于化疗前,静脉化疗组化疗前后的差异具有统计学意义(P<0.05),而腹腔化疗组病人化疗前后的差异无统计学意义(P>0.05)。结论针对老年胃癌患者手术后的免疫特性,宜采用对细胞免疫抑制较轻的腹腔化疗方式进行化疗。 Objective To investigate the effect of intraperitoneal chemotherapy on immune function in elderly patients with gastric cancer after radical operation. Methods From Jan. 1997 to Dec. 2002, NK cell and T cell subgroup of 49 elderly patients with gastric cancer were measured 1 day before and 7 days after intraperitoneal chemotherapy. The results were analyzed with those of normal old people and those of intravenous chemotherapy patients. Results The levels of CD4^+, CD4^+/ CD8^+ and NK cell were lower in elderly patients with gastric cancer than those of the normal old people. The levels of CD4^+, CD4^+/CD8^+ and NK cell decreased in elderly patients with gastric cancer after each intravenous ehemotherapy (P〈0.05) and had no distinct change after each intraperitoneal chemotherapy (P〉0.05). Conclusions It is essential to treat elderly patients with gastric cancer after operation with intraperitoneal chemotherapy, which has less cellular immune damage.
出处 《老年医学与保健》 CAS 2007年第1期27-29,共3页 Geriatrics & Health Care
关键词 胃肿瘤 注射 腹腔内 老年人 免疫 细胞 Stomach neoplasms Injections, intraperitoneal Aged Immunity, cellular
  • 相关文献

参考文献9

  • 1Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer.Jpn J Clin Oncol,1994,24:7~ 11.
  • 2Zhang XY,Chan WY,Whitney BM,et al.T cell receptor Vbeta repertoire express ion reflects gastric carcinoma progression.Clin Immunol,2001,101(1):3~7.
  • 3Jackson PA,Green MA,Marks CG,et al.Lymphocyte suhset infiltration patterns and antigen status in colorectal carcinomas and adenomas.Gut,1996,38(1):85~89.
  • 4曹健,乔颖,陈大伟.胃肠道恶性肿瘤患者NK细胞和T细胞亚群的改变[J].中华肿瘤杂志,1997,19(2):133-133. 被引量:23
  • 5SajiS KuniedaK SugiyamaY etal.Immunoehemotherapy for cancer patients of the stomach——cancer therapy keeping with good host—immunocompetency[J].日本临床医学杂志,2001,59(4):420-426.
  • 6Herhman M J,Cheadle WG,Wellhausen SR,et al.Monocyte HLADR antigen expression characterizes clinical outcome in the trauma patient.Br J Surg,1990,77:204~207.
  • 7Takeuchi H,Maehara Y,Tokunaga E,et al.Prognostic significance of natural killer cell activity in patients with gastric carcinoma:a multivariate analysis.Am J Gastroenterol,2001,96(2):574~578.
  • 8Janunger KG,Hafstrom L,Nygren P,et al.A systematic overview of chenotherapy effects in gastric cancer.Acta Oncol,2001,40(2~3):309~326.
  • 9Ragnhammar P,Hafstrom L,Nygren P,et al.A systematic overview of chemotherapy effects in colorectal cancer.Acta Oncol,2001,40(2~3):282~308.

共引文献22

同被引文献6

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部